Pangenomic Study During Alcoholic Cirrhosis (CDCHC)

September 13, 2021 updated by: Nantes University Hospital

Genetical Predisposition in Hepatocellular Carcinoma : Pangenomic Link Study During Alcoholic Cirrhosis

Hepatocellular carcinoma (HCC) is a frequent complication of cirrhosis. Occurrence of HCC could be linked with multiple functional region of genome.

The determining of a genomic mapping of " single nucleotide polymorphisms " (SNPs) permit to perform some genetic link studies with pathologies without clear hereditary disposition.

In this study, the investigators will identify predictives genetic polymorphism of HCC.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

1325

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Nantes, France, 44000
        • Nantes UH
      • Paris, France, 75000
        • Jean Verdier UH
      • Paris, France, 75000
        • Paul Brousse UH
      • Rennes, France, 35000
        • Rennes UH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

2 groups with 2 subgroups:

  • patient with HCC
  • HCC with Child A
  • HCC with Child B/C
  • patient without HCC
  • Child A without HCC
  • Child B/C without HCC

Description

Inclusion Criteria:

  • 35 to 70 years old
  • Compensated cirrhosis or not
  • Caucasian origin of the parents
  • Patient with cirrhosis (histological proof or obvious)

Exclusion Criteria:

  • HIV, HBV, HCV positive
  • Known Homozygotia (C282Y+/+)
  • Important hepatocytary iron overload for patient with resection
  • HCC non histologically prooved

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
alcoholic cirrhosis with viral infection
patient with alcoholic cirrhosis with viral infection (300 patients)
Genetic: DNA extraction
DNA extraction of blood sample for DNAship analysis
alcoholic cirrhosis without viral infection
patient with alcoholic cirrhosis without viral infection
Genetic: DNA extraction
DNA extraction of blood sample for DNAship analysis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Existence of HCC and Pangenomic analysis of DNA polymorphism
Existence of HCC and determination of which genetic polymorphism are predisposing to HCC or preventing for HCC

Secondary Outcome Measures

Outcome Measure
Measure Description
cirrhosis severity (compensated or not)
Analysis of the genetic polymorphism involved in the severity of cirrhosis

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Nantes University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 23, 2008

Primary Completion (Actual)

December 27, 2011

Study Completion (Actual)

July 20, 2013

Study Registration Dates

First Submitted

February 8, 2010

First Submitted That Met QC Criteria

February 8, 2010

First Posted (Estimate)

February 9, 2010

Study Record Updates

Last Update Posted (Actual)

September 17, 2021

Last Update Submitted That Met QC Criteria

September 13, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BRD/07/08-M

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcoholic Cirrhosis

Clinical Trials on DNA extraction

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe